Zettl U - Search Results

1

Persons with multiple sclerosis older than 55 years: an analysis from the German MS registry.

Goereci Y, Ellenberger D, Rommer P, Dunkl V, Golla H, Zettl U, Stahmann A, Warnke C. Goereci Y, et al. Among authors: zettl u. J Neurol. 2024 Jun;271(6):3409-3416. doi: 10.1007/s00415-024-12286-4. Epub 2024 Mar 22. J Neurol. 2024. PMID: 38517521 Free PMC article.

2

Frequency of current utilisation of complementary and alternative medicine by patients with multiple sclerosis.

Apel A, Greim B, König N, Zettl UK. Apel A, et al. J Neurol. 2006 Oct;253(10):1331-6. doi: 10.1007/s00415-006-0217-9. Epub 2006 Jun 19. J Neurol. 2006. PMID: 16786211

3

Symptomatology of MS: results from the German MS Registry.

Stuke K, Flachenecker P, Zettl UK, Elias WG, Freidel M, Haas J, Pitschnau-Michel D, Schimrigk S, Rieckmann P. Stuke K, et al. J Neurol. 2009 Nov;256(11):1932-5. doi: 10.1007/s00415-009-5257-5. Epub 2009 Jul 23. J Neurol. 2009. PMID: 19629565

4

Sonographic basal ganglia alterations are related to non-motor symptoms in multiple sclerosis.

Horowski S, Zettl UK, Benecke R, Walter U. Horowski S, et al. Among authors: zettl uk. J Neurol. 2011 Feb;258(2):195-202. doi: 10.1007/s00415-010-5707-0. Epub 2010 Aug 26. J Neurol. 2011. PMID: 20740288

5

Rituximab for secondary progressive multiple sclerosis: a case series.

Rommer PS, Patejdl R, Winkelmann A, Benecke R, Zettl UK. Rommer PS, et al. CNS Drugs. 2011 Jul;25(7):607-13. doi: 10.2165/11589390-000000000-00000. CNS Drugs. 2011. PMID: 21699272

6

Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica.

Trebst C, Raab P, Voss EV, Rommer P, Abu-Mugheisib M, Zettl UK, Stangel M. Trebst C, et al. Nat Rev Neurol. 2011 Nov 1;7(12):688-98. doi: 10.1038/nrneurol.2011.176. Nat Rev Neurol. 2011. PMID: 22045269 Review.

7

Failure of natalizumab to prevent relapses in neuromyelitis optica.

Kleiter I, Hellwig K, Berthele A, Kümpfel T, Linker RA, Hartung HP, Paul F, Aktas O; Neuromyelitis Optica Study Group. Kleiter I, et al. Arch Neurol. 2012 Feb;69(2):239-45. doi: 10.1001/archneurol.2011.216. Arch Neurol. 2012. PMID: 22332191

8

Monoclonal antibodies in the treatment of neuroimmunological diseases.

Rommer PS, Patejdl R, Zettl UK. Rommer PS, et al. Curr Pharm Des. 2012;18(29):4498-507. doi: 10.2174/138161212802502125. Curr Pharm Des. 2012. PMID: 22612751 Review.

9

Effect of methylprednisolone on mammalian neuronal networks in vitro.

Wittstock M, Rommer PS, Schiffmann F, Jügelt K, Stüwe S, Benecke R, Schiffmann D, Zettl UK. Wittstock M, et al. Cell Mol Neurobiol. 2015 Jan;35(1):111-4. doi: 10.1007/s10571-014-0117-y. Epub 2014 Oct 5. Cell Mol Neurobiol. 2015. PMID: 25283186

10

Patients characteristics influencing the longitudinal utilization of steroids in multiple sclerosis--an observational study.

Rommer PS, Buckow K, Ellenberger D, Friede T, Pitschnau-Michel D, Fuge J, Stüve O, Zettl UK; German Multiple Sclerosis Registry of the German National MS Society. Rommer PS, et al. Eur J Clin Invest. 2015 Jun;45(6):587-93. doi: 10.1111/eci.12450. Epub 2015 May 9. Eur J Clin Invest. 2015. PMID: 25868705

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

403 results

Search Page

Filters